Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018)

Avanos Medical's Other Accumulated Expenses history spans 1 years, with the latest figure at $29.2 million for Q4 2017.

  • For Q4 2017, Other Accumulated Expenses changed N/A year-over-year to $29.2 million; the TTM value through Dec 2017 reached $29.2 million, changed N/A, while the annual FY2017 figure was $29.2 million, N/A changed from the prior year.
  • Other Accumulated Expenses for Q4 2017 was $29.2 million at Avanos Medical.
  • Across five years, Other Accumulated Expenses topped out at $29.2 million in Q4 2017 and bottomed at $29.2 million in Q4 2017.